Skip to main content
Premium Trial:

Request an Annual Quote

More Than One

Premium

A new diagnostic test called SNaPshot could allow oncologists test their patients for a wide range of mutations in more than one gene at the same time, reports the Guardian's Nic Fleming. This could lead to more personalized treatments as doctors could tailor combination treatments to target all or most of the mutations at once, instead of once at a time, Fleming says. "SNaPshot has been used to identify mutations at more than 50 sites in 14 key genes in patients with non-small-cell lung cancer, and is now being offered to patients with a range of other cancers," he adds. "This is thought to be the first time such a wide-ranging test has been used clinically." The test's developers, who published their study recently in Annals of Oncology, used a multiplex PCR approach to develop the diagnostic.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.